TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35164654

Group type: EXPERIMENTAL
Intervention: Switching group (IES)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Internal focus group (INT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: External focus group (EXT)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: All groups (INT, EXT, IES)
Number of subjects: 79
Study: 34860675

Group type: EXPERIMENTAL
Intervention: ePRO plus usual care
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 142
Study: 36005281

Group type: EXPERIMENTAL
Intervention: ACL repair using dynamic intraligamentary stabilization (DIS)
Number of subjects: 85

Group type: COMPARATOR
Intervention: ACL reconstruction with a semitendinosus tendon autograft
Number of subjects: 85
Study: 34032727

Group type: EXPERIMENTAL
Intervention: Diltiazem (90 mg qd diltiazem sustained-release capsules)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Nicorandil (5 mg tid nicorandil tablets)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Routine drug treatments (aspirin, atorvastatin, betaloc ZOK, perindopril, and isosorbidemononitrate sustained-release tablets)
Number of subjects: 63
Study: 32854772

Group type: EXPERIMENTAL
Intervention: 20 mg OD Rivaroxaban treatment for 11 to 17 days
Number of subjects: 88

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 88
Study: 35622608

Group type: EXPERIMENTAL
Intervention: Two-point regimen in the lower eyelid
Number of subjects: 23

Group type: COMPARATOR
Intervention: One-point regimen in the lower eyelid
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Injection of the pretarsal segment of the upper eyelid
Number of subjects: 23
Study: 34370609

Group type: EXPERIMENTAL
Intervention: Custom exergames and traditional exercise (n=15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Traditional exercise (n=16)
Number of subjects: 31
Study: 32058465

Group type: EXPERIMENTAL
Intervention: Reciprocity-framed message
Number of subjects: 7615

Group type: EXPERIMENTAL
Intervention: Loss-framed message
Number of subjects: 7615

Group type: COMPARATOR
Intervention: Peer-framed message
Number of subjects: 7615

Group type: COMPARATOR
Intervention: Gain-framed message
Number of subjects: 7615

Group type: COMPARATOR
Intervention: Reciprocity-framed message + Peer message
Number of subjects: 7615
Study: 33107033

Group type: EXPERIMENTAL
Intervention: Age-related changes in geometric parameters of middle cerebral artery bifurcations
Number of subjects: 200

Group type: COMPARATOR
Intervention: Comparison of geometric parameters between genders
Number of subjects: 200

Group type: COMPARATOR
Intervention: Non-equal-diameter branches
Number of subjects: 200
Study: 32556710

Group type: EXPERIMENTAL
Intervention: Biofeedback therapy in addition to standard urotherapy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard urotherapy
Number of subjects: 57
Study: 35640494

Group type: COMPARATOR
Intervention: Standard labels
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Linguistically enhanced labels
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Linguistically and graphically enhanced labels
Number of subjects: 66
Study: 33766811

Group type: EXPERIMENTAL
Intervention: Tenapanor plus binder
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo plus binder
Number of subjects: 236
Study: 35200551

Group type: EXPERIMENTAL
Intervention: Gadoxetic acid-enhanced dynamic MRI
Number of subjects: 538

Group type: COMPARATOR
Intervention: Contrast-enhanced computed tomography (CT)
Number of subjects: 538
Study: 34535642

Group type: EXPERIMENTAL
Intervention: CeVICA engineered nanobodies against SARS-CoV-2 RBD
Number of subjects: 1011

Group type: EXPERIMENTAL
Intervention: Affinity maturation and multivalency engineering of nanobodies
Number of subjects: 1011
Study: 35572148

Group type: EXPERIMENTAL
Intervention: Cerebellar vermis iTBS (600 pulses)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study: 32589153

Group type: EXPERIMENTAL
Intervention: Tobbstop mobile app
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Tobbstop mobile app (regular and correct use)
Number of subjects: 773
Study: 35072219

Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia
Number of subjects: 156

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 156
Study: 34816762

Group type: EXPERIMENTAL
Intervention: MN-166 (ibudilast)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 34085883

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Subcostal Transversus Abdominis Plane Block (STAPB)
Number of subjects: 64
Study: 34225724

Group type: EXPERIMENTAL
Intervention: High-frequency level repositioning intervention
Number of subjects: 3300

Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 3300
Study: 36354255

Group type: EXPERIMENTAL
Intervention: Ischemia-free liver transplantation (IFLT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory results from IFLT grafts
Number of subjects: 0
Study: 33233717

Group type: EXPERIMENTAL
Intervention: Blended cognitive–behavioral intervention (integrating face‐to‐face sessions with a web‐based program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual treatment for postpartum depression provided in healthcare centers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blended cognitive–behavioral intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual treatment for postpartum depression
Number of subjects: 0
Study: 34858564

Group type: EXPERIMENTAL
Intervention: Quality nursing intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no quality nursing intervention)
Number of subjects: 74
Study: 32303437

Group type: EXPERIMENTAL
Intervention: Left-sided tumors (KRAS wild-type)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Right-sided tumors (KRAS mutant)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: KRAS mutation
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Prognostic factors
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Anti-EGFR agents exposure
Number of subjects: 700
Study: 35322693

Group type: EXPERIMENTAL
Intervention: Positive end expiratory pressure of 5cm H2O (Group II)
Number of subjects: 2

Group type: COMPARATOR
Intervention: No positive end expiratory pressure (Group I)
Number of subjects: 2
Study: 34313765

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 326

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 326
Study: 32304482

Group type: EXPERIMENTAL
Intervention: Nurse-led computerized cognitive training (CCT) for 4 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Occupational therapist-led computerized cognitive training (CCT) for 4 weeks
Number of subjects: 15
Study: 33097365

Group type: EXPERIMENTAL
Intervention: Voice treatment with physiologic voice therapy plus vocal hygiene program (n = 17)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Vocal hygiene program only (n = 17)
Number of subjects: 34
Study: 33988941

Group type: EXPERIMENTAL
Intervention: Manual therapy and sacroiliac joints home‐based exercise program
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Sacroiliac joints manual therapy and home‐based lumbar exercise program
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Home‐based lumbar exercise program
Number of subjects: 69
Study: 32278735

Group type: EXPERIMENTAL
Intervention: Chronic kidney disease defined by an eGFR < 60 mL/min/1.73 m2
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Nephrotoxic treatment
Number of subjects: 182
Study: 35916347

Group type: EXPERIMENTAL
Intervention: SIGNALS score (0-8 points based on various clinical factors)
Number of subjects: 1542

Group type: EXPERIMENTAL
Intervention: SIGNALS score (training cohort)
Number of subjects: 1542

Group type: EXPERIMENTAL
Intervention: SIGNALS score (validation cohort)
Number of subjects: 1542
Study: 34582480

Group type: EXPERIMENTAL
Intervention: Platelet mitochondrial respiration and CoQ10 levels in RA patients
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 21
Study: 33203167

Group type: EXPERIMENTAL
Intervention: Full feeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trophic feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35482329

Group type: EXPERIMENTAL
Intervention: Moderate-intensity cycling
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Light-intensity cycling
Number of subjects: 114

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 114
Study: 34725044

Group type: EXPERIMENTAL
Intervention: Structured, theoretically driven, self-management group education programme with motivational text-message support
Number of subjects: 353

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 353
Study: 35562205

Group type: EXPERIMENTAL
Intervention: CN-105 (0.03 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CN-105 (0.1 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CN-105 (0.3 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CN-105 (1 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33551165

Group type: COMPARATOR
Intervention: 0 g/d of YS powder
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3 g/d of YS powder
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6 g/d of YS powder
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 9 g/d of YS powder
Number of subjects: 40
Study: 33305817

Group type: EXPERIMENTAL
Intervention: daridorexant 50 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 28
Study: 35168036

Group type: EXPERIMENTAL
Intervention: SIE under normoxia
Number of subjects: 10

Group type: COMPARATOR
Intervention: SIE under systemic hyperoxia (FiO2 = 60%)
Number of subjects: 10
Study: 34363552

Group type: EXPERIMENTAL
Intervention: Preoperative assessment using the ATOP scale
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Postoperative assessment using the ATOP scale 1 year after surgery
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Measurement invariance tests
Number of subjects: 316
Study: 36134520

Group type: EXPERIMENTAL
Intervention: Genetically predicted sleep duration
Number of subjects: 396858

Group type: EXPERIMENTAL
Intervention: Genetically predicted short sleep duration
Number of subjects: 396858

Group type: EXPERIMENTAL
Intervention: Genetically predicted long sleep duration
Number of subjects: 396858
Study: 32696600

Group type: EXPERIMENTAL
Intervention: Daily step count during quarantine
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Average daily step count before and during quarantine
Number of subjects: 26
Study: 35638548

Group type: EXPERIMENTAL
Intervention: Upfront ABVD plus radiation therapy
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Upfront escBEACOPP without radiotherapy
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Baseline TMTV ≥155 mL
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: PET2 response assessment
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Baseline TMTV and PET2 response
Number of subjects: 148
Study: 33843073

Group type: EXPERIMENTAL
Intervention: Thula Sana intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal care (control)
Number of subjects: 64
Study: 32481275

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Battlefield Acupuncture (BFA)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Usual-care wait-list control (WLC)
Number of subjects: 360
Study: 33097977

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg orally 1 hour before ESP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (single session immediately after ESP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo lactose tablets orally 1 hour before ESP
Number of subjects: 60
Study: 36251249

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 2257
Study: 32024790

Group type: EXPERIMENTAL
Intervention: pH 7.2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pH 7.3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pH 7.4
Number of subjects: 0
Study: 32812022

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 254
Study: 33066789

Group type: EXPERIMENTAL
Intervention: Automatic assessment using natural language processing
Number of subjects: 125

Group type: COMPARATOR
Intervention: Manual rating based on a rubric
Number of subjects: 125
Study: 34773489

Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Posterolateral Approach (PLA)
Number of subjects: 20
Study: 36285484

Group type: EXPERIMENTAL
Intervention: Prism adaptation training during standard occupational therapy sessions for three weeks.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard occupational therapy (control group).
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Prism adaptation training (intervention).
Number of subjects: 80
Study: 33124670

Group type: EXPERIMENTAL
Intervention: Preoperative body weight
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Baseline lean mass
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Percent gynoid fat
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Percent body fat
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Insulin independence
Number of subjects: 88
Study: 32945008

Group type: EXPERIMENTAL
Intervention: Surgical ablation for atrial fibrillation (AF)
Number of subjects: 259
Study: 33449097

Group type: EXPERIMENTAL
Intervention: Pharmacy HDDs
Number of subjects: 319

Group type: COMPARATOR
Intervention: Clinically noted HDDs
Number of subjects: 319
Study: 36219243

Group type: EXPERIMENTAL
Intervention: Very Early Mobilization Group (VEMG) - 51 patients received VEMG within 24 hours of the ictus
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual Care Group (UCG) - 53 patients received usual care with mobilization 24 hours after the ictus
Number of subjects: 104
Study: 32885583

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 44
Study: 34612785

Group type: EXPERIMENTAL
Intervention: Brief Mindfulness Meditation (BMM)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 32993818

Group type: EXPERIMENTAL
Intervention: Sandwich dietary pattern (cold cuts, refined grains, cheese and miscellaneous)
Number of subjects: 1845

Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern (produce and whole grains)
Number of subjects: 1845

Group type: EXPERIMENTAL
Intervention: Unhealthy dietary pattern (fried food, savoury snacks and desserts)
Number of subjects: 1845

Group type: EXPERIMENTAL
Intervention: Dairy- and sugar-sweetened beverage-based dietary pattern
Number of subjects: 1845

Group type: EXPERIMENTAL
Intervention: Traditional Mexican dietary pattern
Number of subjects: 1845
Study: 32290122

Group type: EXPERIMENTAL
Intervention: GS mint (4 mg of gymnemic acids)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo mint
Number of subjects: 56
Study: 35381530

Group type: EXPERIMENTAL
Intervention: CHIR-99021 (500, 1,000, 2,000, 5,000, 10,000, 50,000, and 100,000 ng)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Normal Saline (CON)
Number of subjects: 160
Study: 33323501

Group type: EXPERIMENTAL
Intervention: Acute stenting
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Angioplasty and stenting
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Balloon angioplasty and local aspiration
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Not stenting acutely
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: General agreement among practitioners
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Willingness to participate in a trial
Number of subjects: 220
Study: 34274555

Group type: EXPERIMENTAL
Intervention: Pecan-containing meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no nuts)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Black walnuts
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: English walnuts
Number of subjects: 10
Study: 34191594

Group type: EXPERIMENTAL
Intervention: Home-based palliative care (HBPC)
Number of subjects: 93
Study: 32362412

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance for lateral popliteal block
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nerve stimulation for lateral popliteal block
Number of subjects: 0
Study: 32891709

Group type: EXPERIMENTAL
Intervention: n-acetylcysteine 1.2 g
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: n-acetylcysteine 2.4 g
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 35431792

Group type: EXPERIMENTAL
Intervention: High frequency group (HF group) - MI‐BCI training once per day for 10 sessions
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low frequency group (LF group) - MI‐BCI training once every other day for 10 sessions
Number of subjects: 16
Study: 32588088

Group type: EXPERIMENTAL
Intervention: Radiomic model based on 9 selected radiomic features
Number of subjects: 235

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Complex model (combination of radiomic and clinical models)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Radiomic model
Number of subjects: 235
Study: 34929381

Group type: EXPERIMENTAL
Intervention: Mechanical Percutaneous Disc Decompression (PDD)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Percutaneous Radiofrequency Targeted Disc Decompression (TDD)
Number of subjects: 200
Study: 34118709

Group type: EXPERIMENTAL
Intervention: Cognitive insight measured by the Beck Cognitive Insight Scale (BCIS) - Self-Reflection
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Cognitive insight measured by the Beck Cognitive Insight Scale (BCIS) - Self-Certainty
Number of subjects: 152

Group type: COMPARATOR
Intervention: Medication adherence
Number of subjects: 152

Group type: COMPARATOR
Intervention: Methamphetamine use days
Number of subjects: 152
Study: 32776099

Group type: EXPERIMENTAL
Intervention: Nomogram including age, race, tumor site, depth of tumor invasion, lymph node status, distant metastasis, tumor size, surgery, chemotherapy and radiotherapy.
Number of subjects: 737

Group type: COMPARATOR
Intervention: SEER stage
Number of subjects: 737

Group type: COMPARATOR
Intervention: American Joint Committee on Cancer stage
Number of subjects: 737
Study: 35596008

Group type: EXPERIMENTAL
Intervention: Canola Oil (CO)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Sesame Oil (SO)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Sesame-Canola Oil (SCO)
Number of subjects: 282
Study: 33877440

Group type: EXPERIMENTAL
Intervention: NAPP (Free gingival graft + NAPP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (FGG alone)
Number of subjects: 40
Study: 34405878

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 997

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 997
Study: 32299470

Group type: EXPERIMENTAL
Intervention: Personalized Tobacco Care Management (PTCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quitline eReferral
Number of subjects: 0
Study: 35435937

Group type: EXPERIMENTAL
Intervention: Awake prone positioning intervention
Number of subjects: 501

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 501
Study: 32820955

Group type: EXPERIMENTAL
Intervention: Virtual cycling experience (25-minute, self-paced, facilitated seated)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Seated physical activity session (time-matched)
Number of subjects: 10
Study: 35921023

Group type: EXPERIMENTAL
Intervention: Matcha tea
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (LCD diet only)
Number of subjects: 40
Study: 32592749

Group type: EXPERIMENTAL
Intervention: Genetically increased BMI (by one standard deviation)
Number of subjects: 500000
Study: 36468322

Group type: EXPERIMENTAL
Intervention: Mental health training intervention
Number of subjects: 205
Study: 33503901

Group type: EXPERIMENTAL
Intervention: Minimally invasive esophagectomy (MIE)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Open esophagectomy (OE)
Number of subjects: 104
Study: 32249311

Group type: EXPERIMENTAL
Intervention: Thiopental infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34711629

Group type: EXPERIMENTAL
Intervention: Baseline serum levels of choline (Q4)
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Baseline serum levels of betaine (Q4)
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Baseline serum levels of phenylacetylglutamine (Q4)
Number of subjects: 692
Study: 34713825

Group type: EXPERIMENTAL
Intervention: Danhong injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32789505

Group type: COMPARATOR
Intervention: Alum only (control group)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Low-dose (2.5 μg/dose)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Medium-dose (5 μg/dose)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: High-dose (10 μg/dose)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Vaccine (5 μg/dose) on days 0 and 14
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Vaccine (5 μg/dose) on days 0 and 21
Number of subjects: 320
Study: 33587542

Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 0
Study: 32259645

Group type: EXPERIMENTAL
Intervention: Interconnected Knotless Anchor (IKA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Double Knotless Anchor (DKA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Interference Screw (IS)
Number of subjects: 24